Citation Impact
Citing Papers
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses
2006
Caenorhabditis elegans ADAR editing and the ERI-6/7/MOV10 RNAi pathway silence endogenous viral elements and LTR retrotransposons
2020 StandoutNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Factors associated with spontaneous clearance of chronic hepatitis C virus infection
2016
The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation
2021 Standout
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
2013 StandoutNobel
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Oral diseases: a global public health challenge
2019 Standout
Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis
2017
Human Endogenous Retroviruses in Neurological Diseases
2018
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
How Stable Is the Hepatitis C Virus (HCV)? Environmental Stability of HCV and Its Susceptibility to Chemical Biocides
2010
A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
2005 Standout
Interferón en la hepatitis B
2008
Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups
2018
Leishmaniasis
2018 Standout
Acute hepatitis C and HIV coinfection
2009
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B
2008
Serum Hbv Dna As A Marker of Efficacy During Therapy for Chronic Hbv Infection: Analysis and Review of the Literature
2003
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Hepatocellular carcinoma
2018 Standout
Molecular epidemiology of endemic Clostridium difficile infection
2001
Wearable biosensors for healthcare monitoring
2019 Standout
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients
2007
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Burden of liver diseases in the world
2018 Standout
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
2014
Management of Hepatic Complications in HIV‐Infected Persons
2008
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
2010
Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS
2015
Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
2003
Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness
2008 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Type I interferons in infectious disease
2015 Standout
Hepatitis B virus infection
2009 Standout
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management
2005
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
2005 Standout
Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
2009
The changing epidemiology of hepatitis C virus infection in Europe
2007
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
2005
Guideline for hand hygiene in health-care settings
2002 Standout
Acute hepatitis C: Current status and remaining challenges
2008
Recent developments on the role of Clostridium difficile in inflammatory bowel disease
2008
Global Burden of Tuberculosis
1999 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
2010 Standout
PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
2014
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
1996
Guideline for Hand Hygiene in Health-Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force
2002 Standout
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
Chronic hepatitis B
2007 Standout
Transmission of Hepatitis C Virus Infection Through Tattooing and Piercing: A Critical Review
2012
The Role of Physical Proximity in Nosocomial Diarrhea
2000
Risk factors for hepatitis E virus infection and disease
2014
Chronic hepatitis B: Update 2009 #
2009 Standout
Clostridium difficileSmall Bowel Enteritis Occurring after Total Colectomy
2001
Multicenter Typing Comparison of Sporadic and OutbreakClostridium difficileIsolates from Geographically Diverse Hospitals
1997
Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders
2009
Gut flora in health and disease
2003 Standout
Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea
1996
Tuberculosis Serodiagnosis in a Predominantly HIV-Infected Population of Hospitalized Patients with Cough, Botswana, 2002
2004
Hepatitis C: global epidemiology and strategies for control
2016
Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study
2006
Is there a role for viruses in triggering autoimmune hepatitis?
2003
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
2012
Hepatitis B virus and hepatitis C virus dual infection
2014
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
2004
Acute Hepatitis C: A Systematic Review.
2008
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Anaerobic Bacteria in Postsurgical Infections: Isolation Rate and Antimicrobial Susceptibility
1996
Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
2005
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling
2006
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Ledipasvir–sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial
2017
Biomarkers for tuberculosis disease activity, cure, and relapse
2009
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
1995
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Molecular typing methods for the epidemiological identification of Clostridium difficile strains
2001
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Wound Microbiology and Associated Approaches to Wound Management
2001 Standout
A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone
2005
Wearable sweat sensors
2018
Nanomaterial-based Electrochemical Biosensors
2022
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
An Ensemble Learning Approach for Enhanced Classification of Patients With Hepatitis and Cirrhosis
2021
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Antiretroviral drugs and liver injury
2008
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Vaginal antibody of patients with trichomoniasis is to a prominent surface immunogen of Trichomonas vaginalis.
1991
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Recent Advances in Ultrathin Two-Dimensional Nanomaterials
2017 Standout
Clinical and Microbiological Aspects ofTrichomonas vaginalis
1998 Standout
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
Works of Sergio Babudieri being referenced
Profile of Patients Triply Infected with HIV and the Hepatitis B and C Viruses in the HAART Era
2008
Liver Enzyme Elevation in Hepatitis C Virus (HCV)–HIV-Coinfected Patients Prior to and after Initiating HAART: Role of HCV Genotypes
2006
Anaerobic Bacteria and Bacterial Infections: Perspectives on Treatment and Resistance in Italy
1990
Risk Factors and Outcome among a Large Patient Cohort with Community-Acquired Acute Hepatitis C in Italy
2006
Evidence for cross-infection in an outbreak of Clostridium difficile-associated diarrhoea in a surgical unit
1988
Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs
2006
Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis?
2013
Correlates ofMycobacterium tuberculosisinfection in a prison population
2005
Effectiveness of a multi‐disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes
2007
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin
2014
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era?
2012
Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial
2001
A young woman with hepatitis after a sore throat
1995
Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis
2008
Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy
2012
Early Abnormalities of the Antibody Response against Mycobacterium tuberculosis in Human Immunodeficiency Virus Infection
1993
Incidence of Neutropenia and Infections During Combination Treatment of Chronic Hepatitis C with Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin
2008
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay
1999
Mucocutaneous leishmaniasis as presentation of HIV infection in Sardinia, insular Italy
2013
Use of Pegylated Interferons is Associated with An Increased Incidence of Infections during Combination Treatment of Chronic Hepatitis C: A Side Effect of Pegylation?
2004
The De Ritis ratio as prognostic biomarker of in‐hospital mortality in COVID‐19 patients
2020
Isolation of Clostridium difficile from human jejunum: identification of a reservoir for disease?
1986
Enzyme Biosensors for Biomedical Applications: Strategies for Safeguarding Analytical Performances in Biological Fluids
2016